Can we optimise the TB response amid funding constraints using evidence-based, cost-effective strategies
Abstract
Background: Despite progress in the TB response, including through the Global Fund's catalytic efforts, funding gaps and inefficiencies threaten efforts to sustain gains and accelerate the TB response. Recent donor funding cuts have further strained programmes in low- and middle-income countries.
Methods: A mixed-method, combining desk and literature review and key informant interviews with national TB programme stakeholders, technical experts, and partners, was conducted using standardised tools. Findings were triangulated to identify strategies/approaches that improve efficiency, access, and outcomes.
Results: We identified cost-effective strategies that optimise resources and tools to sustain and expand access to services amid declining funding. Strategies to enhance efficiency include screening using digital X-rays (with artificial intelligence), testing samples (including pooled samples) with molecular diagnostics, decentralising care, engaging communities and private sector, and integrating TB services with broader health system. Cost-saving measures involve integrated sample transport and supervision, integrating TB with other diseases such as HIV, diabetes, and undernutrition, task shifting, shorter treatment regimens, digital tools, and e-learning. Emphasis was also placed on innovative financing, domestic resource mobilisation, and country ownership.
Conclusion: Accelerating to end TB requires integrated and efficient strategies, innovative financing, and increased…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.